<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type='text/xsl' href='/oai2.xsl' ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
         xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
<responseDate>2026-10-08T13:02:59Z</responseDate>
<request identifier="oai:lup.lub.lu.se:848bf8ca-5c98-4298-a186-0f4b9bce68f8" metadataPrefix="oai_dc" verb="GetRecord">https://lup.lub.lu.se/oai</request>

<GetRecord>
<record>
<header>
    <identifier>oai:lup.lub.lu.se:848bf8ca-5c98-4298-a186-0f4b9bce68f8</identifier>
    <datestamp>2025-07-28T19:30:29Z</datestamp>
    <setSpec>allFtxt</setSpec>
    <setSpec>allFtxt</setSpec>
    <setSpec>thesis</setSpec>
    <setSpec>thesis:ftxt</setSpec>
    <setSpec>thesis:doccomp</setSpec>
    <setSpec>thesis:doccomp:ftxt</setSpec>
</header>

<metadata>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"> <dc:title>Targeting the human papillomavirus for prevention of cervical cancer</dc:title> <dc:identifier>https://lup.lub.lu.se/record/548843</dc:identifier> <dc:identifier>urn:isbn:978-91-85559-75-6</dc:identifier> <dc:identifier>https://portal.research.lu.se/files/4621169/548844.pdf</dc:identifier> <dc:creator>Naucler, Pontus</dc:creator> <dc:description>Different types of human papillomavirus (HPV) vary in the extent they cause precursor lesions (CIN) and cancer. There are limited long-term efficacy data on HPV testing in primary screening Among 72 cervical cancers in Mozambique, HPV 16 and 18 were the most frequent HPV types (69% of cases). Comparing 108 cervical cancers cases and 517 matched controls nested within a population-based cohort in Taiwan, HPV 16 seropositivity implied a 6-fold increased cancer risk. In a cohort of 5696 women in Sweden, HPV types 16, 31 and 33 conveyed the highest risks for future high-grade CIN (CIN 2+), attributing to 33.1%, 18.3% and 7.7% of CIN 2+ cases, respectively. In a pooled analysis of seven European longitudinal studies of HPV-based cervical screening, the cumulative incidence rate of CIN grade 3 or worse (CIN 3+) was higher after 3 years among women with normal cytology than among women with a negative HPV test after 6 years. Finally, in a randomized cervical cancer screening trial in Sweden, adding testing for HPV persistence resulted in a 51% (95% CI: 13-102) increase of CIN 2+ at prevalent screening, which was followed by a reduction of 42% (95% CI: 4-76) of CIN 2+ at incident screening. In conclusion, HPV-based cervical cancer screening protects against future CIN 2+, and the long-term protective effect should enable extended screening intervals to 6 years. Albeit HPV 16 is the most important carcinogenic HPV type all over the world, different ?high-risk? HPV types convey distinctly different risks for CIN 2+, which should be considered in design of screening tests and vaccines.</dc:description> <dc:subject>Microbiology in the Medical Area</dc:subject> <dc:subject>bakteriologi</dc:subject> <dc:subject>virologi</dc:subject> <dc:subject>Mikrobiologi</dc:subject> <dc:subject>mycology</dc:subject> <dc:subject>virology</dc:subject> <dc:subject>bacteriology</dc:subject> <dc:subject>prevention</dc:subject> <dc:subject>Microbiology</dc:subject> <dc:subject>CIN</dc:subject> <dc:subject>vaccine</dc:subject> <dc:subject>cervical intraepithelial neoplasia</dc:subject> <dc:subject>screening</dc:subject> <dc:subject>cervical cancer</dc:subject> <dc:subject>Human Papillomavirus</dc:subject> <dc:subject>HPV</dc:subject> <dc:subject>mykologi</dc:subject> <dc:subject>Public health</dc:subject> <dc:subject>epidemiology</dc:subject> <dc:subject>Folkhälsa</dc:subject> <dc:subject>epidemiologi</dc:subject> <dc:language>eng</dc:language> <dc:publisher>Medical Microbiology, Lund University</dc:publisher> <dc:date>2007</dc:date> <dc:rights>info:eu-repo/semantics/openAccess</dc:rights> <dc:type>thesis/doccomp</dc:type> <dc:type>info:eu-repo/semantics/doctoralThesis</dc:type> <dc:type>text</dc:type> <dc:format>application/pdf</dc:format> </oai_dc:dc>
</metadata>
</record>
</GetRecord>
</OAI-PMH>

